Skip to main content
Internal Medicine logoLink to Internal Medicine
. 2019 Apr 17;59(1):7–14. doi: 10.2169/internalmedicine.2373-18

Management of Dysphagia in Patients with Parkinson's Disease and Related Disorders

George Umemoto 1, Hirokazu Furuya 2
PMCID: PMC6995701  PMID: 30996170

Abstract

Various methods of rehabilitation for dysphagia have been suggested through the experience of treating stroke patients. Although most of these patients recover their swallowing function in a short period, dysphagia in Parkinson's disease (PD) and Parkinson-related disorder (PRD) degenerates with disease progression. Muscle rigidity and bradykinesia are recognized as causes of swallowing dysfunction, and it is difficult to easily apply the strategies for stroke to the rehabilitation of dysphagia in PD patients. Disease severity, weight loss, drooling, and dementia are important clinical predictors. Silent aspiration is a pathognomonic sign that may lead to aspiration pneumonia. Severe PD patients need routine video fluoroscopy or video endoscopy to adjust their food and liquid consistency. Patients with PRD experience rapid progression of swallowing dysfunction. Nutrition combined with nasogastric tube feeding or percutaneous endoscopic gastrostomy feeding should be considered owing to the increased risk of aspiration and difficulty administrating oral nutrition.

Keywords: dysphagia, video fluoroscopy, video endoscopy, aspiration pneumonia, Parkinson's disease, Parkinson-related disorder

Introduction

The reported prevalence of dysphagia in patients with Parkinson's disease (PD) ranges from 18.5% to 100% due to variations in the methods of assessing the swallowing function (1,2). Pneumonia is a main cause of death in PD (4-30%) (3-6); however, few reports have so far described any significantly effective therapies for dysphagia in PD.

Strategies for the assessment and rehabilitation of dysphagia have been established in the treatment of stroke patients. The effectiveness of most traditional dysphagia therapies, such as volume and texture modification, chin tuck (7,8), head turn (9,10), effortful swallow (11-13), supraglottic swallow (14,15), Mendelsohn maneuver (16,17), and Shaker exercise (18,19), have been confirmed in patients with stroke but not in those with PD. The Mendelssohn maneuver is an effective procedure for the activation of the swallowing muscles and the opening of the upper esophageal sphincter using remedial treatment. The Shaker exercise is a series of sustained and repetitive head lifting exercises to enhance the strength of the infrahyoid and suprahyoid muscles. These exercises are particularly applicable to stroke treatment that requires a short-term effect; however, these may not always be appropriate for PD that requires long-term follow-up. Furthermore, not only exercises but also compensatory techniques, such as volume and texture modification, are reported to be of minor benefit for the PD prognosis (20).

In this review article, we outline the current quantitative management of dysphagia in PD patients and Parkinson-related disorder [PRD; e.g. progressive supranuclear palsy (PSP) and multiple system atrophy (MSA)].

Traditional Dysphagia Assessments and Therapies in Stroke

More than 50% of stroke survivors experience dysphagia; however, most of them recover their swallowing function within a week (21). The proportion of stroke survivors with dysphagia at 6 months is reported to be approximately 11-13% (22). Constant awareness and review of swallowing are needed after stroke because of the diverse course of the symptoms over the six subsequent months. The assessment and management of dysphagia are important for minimizing the risk of food and liquid aspiration as well as pneumonia.

Screening for dysphagia includes the water-swallowing test (using 5-30 mL water) and repetitive saliva-swallowing test. To assess the swallowing dysfunction in detail and detect silent aspiration, a video fluoroscopic swallowing study (VFSS) or fiberoptic endoscopic evaluation of swallowing (FEES) should be used. A VFSS provides information on bolus flow, the movement of each organ, and the anatomy (23,24). A FEES can be performed even at the bedside and is able to detect silent saliva aspiration.

Depending on the onset and course of stroke and dysphagia severity, a nasogastric tube (NGT) should be placed early to allow the administration of nutrition and medication. However, percutaneous endoscopic gastrostomy (PEG) should be considered during the first several weeks after stroke onset (25). PEG is not recommended as a first-line treatment for patients whose swallowing function is on the mend. Delayed nutritional supply or the long-term use of an NGT will influence the rehabilitation effect. If the use of an NGT is likely to be extended for a long-term period, the need for PEG feeding should be discussed without hesitation.

The prevalence of aspiration pneumonia in stroke patients is reported to be 7-22% (26); however, food aspiration is potentially more lethal than aspiration pneumonia. Therefore, the diet served immediately after acute stroke in patients with dysphagia findings should be adjusted based on the findings of a VFSS or FEES. Oral hygiene is also important, and mouth care reduces the incidence of aspiration pneumonia (27,28). In contrast, prophylactic antibiotics cannot be used as an effective treatment strategy for pneumonia in patients with dysphagia (29,30).

The traditional rehabilitation strategies for dysphagia include volume and texture modifications, strategies of forceful swallow, double swallow, breath holding, supraglottic swallow, super-supraglottic swallow, Mendelsohn maneuver, head turn, chin tuck, and Shaker exercise (31). Compensatory swallowing strategies, volume and texture modifications, chin tuck, head tilt, and head turn aim to maintain and ensure safe drinking and eating mainly in the acute and recovery stages (Table 1). In contrast, swallowing exercises, effortful swallow, supraglottic swallow, super-supraglottic swallow, and Mendelsohn maneuver are performed for compensatory and rehabilitative purposes occasionally in the long term. In particular, the goal of the Shaker exercise is simply to improve the swallowing function. Of note, these compensatory swallowing strategies and swallowing exercises may be used in combination to manage dysphagia secondary to stroke.

Table 1.

Main Traditional Dysphagia Therapies.

Way of responding Purpose
Environmental coordination Adaptive eating environment To concentrate on eating
Adaptive eating utensils To enable the handling of food or to put the food on the back of the tongue
Adjustment of body position Chin tuck To narrow the entrance of the larynx, thereby preventing aspiration and reducing pharyngeal residue
Head turn To expand the contralateral pyriform sinus ensuring pathway
Head tilt To use gravity to ensure the ipsilateral pathway
Reclining position To use gravity to help transport the bolus to the pharynx and prevent aspiration
Texture modification Chopped diet To compensate for impaired mastication
Pureed diet To compensate for impaired mastication and bolus formation
Adding thickness To increase the viscosity and cohesiveness of food and slow the transport speed
Compensatory techniques Repeated swallows To reduce the pharyngeal residue
Alternate liquid and solid swallow To trigger the swallowing reflex and reduce pharyngeal residue
Supraglottic swallow To prevent swallowed food or liquid from entering the airway

Shaded rows: long-term therapies

Progression and Management of Dysphagia in PD

Unlike stroke, dysphagia in PRD degenerates with disease progression. Although their swallowing dysfunction is assessed by using VFSS or FEES, rehabilitation is required for determining PD patients' quality of life. A transdisciplinary approach, including physicians, nurses, physical therapists, speech pathologists, and nutritionists, is required for long-term management.

Two specific questionnaires have been developed to detect dysphagia in PD: the swallowing disturbance questionnaire (SDQ) (32) and the Munich Dysphagia test-Parkinson's disease (MDT-PD) (33). The SDQ containing 15 questions is more basic and an easier screening test for asking about specific symptoms with dysphagia and their frequencies. The MDT-PD can detect the beginning of oropharyngeal symptoms and the risk of laryngeal penetration or aspiration. It consists of 26 items divided into 4 categories: (1) difficulty in swallowing food and liquids, (2) difficulty in swallowing independent of food intake, (3) further swallowing-specific and associated problems, (4) swallowing-specific health questions.

Because of the low association between patients' self-reported swallowing condition and their actual swallowing function, an FEES or VFSS is essential for the assessment of dysphagia in PD. The FEES can evaluate the pharyngeal conditions during a sequence of swallows with various liquids and foods from everyday life. No standard protocol has been established for the FEES focused on dysphagia in PD, but the penetration-aspiration scale (PAS) (34) is useful for evaluating the risk of aspiration and the patient's airway clearance ability. In contrast, the VFSS allows examiners to assess abnormal findings in the oral, pharyngeal, and esophageal phases of swallowing. Although the VFSS dysphagia scale with a sum of 100 is a useful assessment tool (35), a recent study narrowed down the list of items to the following 4 as the PD VFSS scale: mastication, lingual motility prior to transfer, aspiration, and total swallow time (36).

The extrapyramidal dysfunction induced by disturbances of the dopaminergic mechanism, which involves the degeneration of dopaminergic neurons in the substantia nigra, plays an important role in the pathophysiology of dysphagia in PD patients (37-39). Although the treatment of extrapyramidal signs should be prioritized, increasing doses of L-Dopa is not guaranteed to improve swallowing disturbances. The medullary swallowing central pattern generator, affected by Lewy bodies which appear in different non-dopaminergic brainstem and cortical areas (40,41), can also impair the sequential swallowing pattern. In addition, the presence of alpha-synuclein in peripheral sensory and cholinergic dysfunction can affect the pharyngeal muscles and induce pharyngeal swallowing dysfunction (42,43).

Although the prevalence of dysphagia in PD patients is unclear (1,2), the rate surprisingly increases from 15 years after the onset in the course of long-term clinical PD (44-48) (Table 2). There is a gap in the dysphagia prevalence between subjectively reported (35%) and objectively confirmed (82%) cases (44). However, in most PD patients, severe dysphagia appears in the advanced stage (49,50). Hoehn and Yahr stages 4 and 5 (51), relevant weight loss or a body mass index <20 kg/m2 (52,53), drooling or sialorrhea (54), and dementia (55) have drawn attention as clinical predictors of dysphagia in PD patients (56). The high frequency of silent aspiration (15%) is characteristic of dysphagia in PD (57) and may lead to unrecognized dysphagia and aspiration pneumonia in severe cases.

Table 2.

Differences in the Characteristics of Dysphagia between Stroke and Parkinson-related Disorders.

Stroke Parkinson-related disorders
Course of the disease <1 month in 90%; ≥1 month in 10% Long-term period, mostly >10 years
Assessment of dysphagia before and after rehabilitation emergency and routine assessment, every year (advanced PD and PRD) or once in every few years (moderate PD)
Impact of the pathological condition location of stroke and paralyzed side degree of parkinsonism and on/off status
Impact of medication prevention of recurrence off state and levodopa-induced dyskinesia
Impact of complications decreased level of consciousness cognitive impairment, psychiatric state, and malnutrition/weight loss
Pathology pseudobulbar paralysis and pharyngeal muscle paralysis pharyngeal hypokinesia and dysrhythmic swallowing movements
Clinical symptoms highly frequent aspiration pneumonia in the early stage of onset highly frequent silent aspiration and pneumonia in the advanced stage
Characteristic findings in VFSS delayed or absent swallowing reflex, unilateral pharyngeal residue, reduced laryngeal closure, and pharyngeal sensation delayed transport, repetitive tongue pumping, delayed swallowing reflex, reduced laryngeal elevation, pharyngeal residue, and silent aspiration
Rehabilitation strategy restoration of the swallowing function maintenance of the swallowing function
Effects of rehabilitation effective in the early stage of onset effective in the short term, skeptical in the long term
Prognosis restorative in 90% within 1 month of onset progressive (PD, slow; PRD, fast)

One of the main causes of death in PD patients is pneumonia (4-30%) (58-61). Incidental choking on food and saliva does not always lead to aspiration pneumonia; however, the reduced resistance of the host and decreased pulmonary clearance increase the likelihood of aspiration pneumonia (61,62). Deteriorated sensitivity and intensity of cough reflex also influence the risk of aspiration pneumonia (63). Aspiration pneumonia was the most common reason for the emergency admission of patients with PD whose disease duration was >5 years (64). Most of them exhibited abnormalities on their VFSS, cognitive impairment, and a history of psychiatric symptoms.

Dopaminergic medication does not necessarily improve the swallowing function. PD patients often show an improved swallowing function and reduction in other symptoms after the adjustment of medications (65,66). Some studies have suggested that dysphagia in PD is statistically resistant to dopaminergic stimulation (67,68). Another study suggested that the risk of aspiration may remain unchanged with levodopa (69). Further studies are needed to confirm the difference in the risk of aspiration between on and off states of levodopa. The non-dopaminergic pathway may play an important role in dysphagia in patients with PD that is linked to a reduction in the basal ganglia dopamine activity or neurotransmitter systems as well as in the peripheral mechanisms (70).

Deep brain stimulation (DBS), including subthalamicus nucleus (STN) and globus pallidus internus (GPi) stimulation, has also not shown clinically significant effects on the swallowing function in the on and off states (71-76). Although some studies have reported that STN caused more impairment to the swallowing function than GPi (65,77), there are no experimental studies directly comparing the impact on the swallowing function between STN and GPi. These results suggest that the swallowing function may have limited relevance to parkinsonian motor ability (76). However, a recent study suggested that 60 Hz DBS of bilateral STN significantly reduced the aspiration frequency compared with routine DBS at 130 Hz (78). Low-frequency STN stimulation may therefore be effective for dysphagia in PD patients.

Muscle rigidity and bradykinesia observed in PD are recognized causes of swallowing dysfunction. In most PD patients, dysphagia is related to abnormal movements, including labial bolus leakage, deficient or hesitant mastication, lingual tremor, lingual pumping, prolonged lingual elevation, and slower and limited mandibular excursion in the oral phase (79,80) (Table 3). Common symptoms, including pharyngeal residue, somatosensory deficits, and a reduced rate of spontaneous swallowing in the pharyngeal phase as well as hypomotility, spasms, and multiple contractions in the esophageal phase (56), constitute abnormal swallowing movements. Abnormal movements in the oral phase induced by mandibular and lingual bradykinesia typified by lingual pumping are particularly characteristic of PD (50,81,82) (Figure). Therefore, it is difficult to easily apply the strategies used for treating stroke to the rehabilitation of dysphagia patients with PD.

Table 3.

Characteristics of Dysphagia in Parkinson’s Disease.

Characteristic symptoms
oral phase impaired lingual and masticatory movement, jaw rigidity, drooling, dry mouth, hesitation to swallow, oral residue
pharyngeal phase delayed swallow reflex, aspiration, diminished pharyngeal peristalsis and laryngeal elevation, pharyngeal residue in epiglottic vallecular and pyriform sinus, impaired laryngeal and pharyngeal movement due to dropped head or rigidity of neck muscles
esophageal phase dysfunction of the upper esophageal sphincter, diminished esophageal peristalsis, gastroesophageal reflux

Figure.

Figure.

The trajectory of tongue movements in video fluoroscopy. Lingual movements to transport the bolus from the oral cavity to the pharynx even in patients with stroke who have an adequate oral function seem to be achieved by the coordination of the dorsum-root of the tongue (a). In contrast, patients with Parkinson’s disease (PD) often show a specific oral phase characterized by lingual pumping without the coordination of the dorsum-root of the tongue and need more time for the transportation of the bolus (b).

The effectiveness of a few rehabilitation methods has already been proven. However, some studies have reported that expiratory muscle strength training (EMST) is effective for swallowing training in PD patients (83-86). They suggested that EMST enforces the ability to cough and remove unwanted material from the airway. Another study evaluated the Lee Silverman Voice Treatment (LSVT) that seemed effective for improving the oral tongue and tongue base function during the oropharyngeal phase of swallowing (87). Further research is necessary to establish methods for managing oropharyngeal dysphagia in PD patients. At present, traditional dysphagia therapies for stroke patients should be applied for a sudden deterioration in the swallowing function related to pneumonia, and EMST is an alternative approach for the long-term management of dysphagia in PD.

Strategy for Rapidly Progressive Dysphagia in PRD, PSP, and MSA

Dysphagia symptoms in PRD, PSP, and MSA appear earlier after the onset than in PD (88). The median dysphagia latencies were reported to be 42 months in PSP, 67 months in MSA, and 130 months in PD. This suggests that early dysphagia symptoms in PRD are distinguishable from those in PD.

In PSP, the most common cause of death is pneumonia (89) that occurs subsequent to silent aspiration (90). The reported prevalence of dysphagia in PSP is up to 80%, and the early development of dysphagia leads to repeated aspiration pneumonia and a short survival time (91). Medication, adjustment of food consistency, feeding techniques, and PEG feeding should be attempted in order to prevent pneumonia. Relative to PD patients, PSP patients exhibit a poorer response to medications with mild improvement in dysphagia (92,93), and the management of dysphagia in the later stages of PSP is more challenging than in the earlier stages. The early deterioration of the cognitive function or dementia may influence the treatment difficulty. However, despite adjusting the food consistency and feeding techniques, most PSP patients ultimately require PEG feeding within a few months after the initial development of pneumonia (94). Nevertheless, whether or not PEG placement prolongs the survival time (actuarially corrected to 6-10 years) is unclear (95-97).

MSA patients have a similar survival duration to PSP patients. A prospective European cohort study reported a median survival time from symptom onset of 9.8 years (98). Severe dysautonomia and early falls were reported to be indicators of a shortened survival time (99). Furthermore, the time from the initial symptom onset to the appearance of other symptoms, indicating the progression of MSA, is associated with the deterioration of activities of daily living (ADL) and a shortened survival (100). Dysphagia may influence the association between ADL deterioration and the survival time. In fact, the disease duration and ADL were shown to be correlated with the dysphagia score, particularly with the pharyngeal phase score of MSA with predominant parkinsonism (101).

A routine VFSS or FEES is recommended mainly for PD patients in advanced disease stages (Hoehn and Yahr stages 4 and 5) to adjust the food and liquid consistency. Patients with mild PD commonly show slight changes on clinical swallowing examinations. In contrast, patients with PRD, PSP, and MSA experience rapid progression of swallowing dysfunction. Therefore, the appearance of dysphagia symptoms in PRD suggests the need for more frequent assessments than in PD in order to prevent the risk of aspiration and choking on food. If the risk of aspiration increases and the management of oral nutrition is difficult, nutrition combined with NGT or PEG feeding should be considered.

The establishment of a guideline for the treatment and rehabilitation of dysphagia in PD and PRD is expected. Individual-targeted reliable treatment and rehabilitation plans based on the clinical course and findings of each patient are desirable. However, it is difficult to gather large amounts of data unifying examination and assessment standards for PD patients, given their diverse clinical courses and findings. Big-data analyses of VFSS or FEES images collected from a homogeneous PD patient group are still far from reality. Nevertheless, they may eventually aid in the prediction of the prognosis of each patient and help physicians formulate strategies for ensuring these patients' safe swallowing and adequate nutrition.

The authors state that they have no Conflict of Interest (COI).

References

  • 1. Clarke CE, Gullaksen E, Macdonald S, Lowe F. Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson's disease. Acta Neurol Scand 97: 27-35, 1998. [DOI] [PubMed] [Google Scholar]
  • 2. Coates C, Bakheit AM. Dysphagia in Parkinson's disease. Eur Neurol 38: 49-52, 1997. [DOI] [PubMed] [Google Scholar]
  • 3. Yoritaka A, Shimo Y, Takanashi M, et al. Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks. Parkinsonism Relat Disord 19: 725-731, 2013. [DOI] [PubMed] [Google Scholar]
  • 4. Sato K, Hatano T, Yamashiro K, et al. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21: 1384-1395, 2006. [DOI] [PubMed] [Google Scholar]
  • 5. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 103: 7-11, 2001. [DOI] [PubMed] [Google Scholar]
  • 6. Langmore SE, Terpenning MS, Schork A, et al. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia 13: 69-81, 1998. [DOI] [PubMed] [Google Scholar]
  • 7. Welch MV, Logemann JA, Rademaker AW, Kahrilas PJ. Changes in pharyngeal dimensions effected by chin tuck. Arch Phys Med Rehabil 74: 178-181, 1993. [PubMed] [Google Scholar]
  • 8. Ra JY, Hyun JK, Ko KR, Lee SJ. Chin tuck for prevention of aspiration: effectiveness and appropriate posture. Dysphagia 29: 603-609, 2014. [DOI] [PubMed] [Google Scholar]
  • 9. Logemann JA, Kahrilas PJ, Kobara M, Vakil NB. The benefit of head rotation on pharyngoesophageal dysphagia. Arch Phys Med Rehabil 70: 767-771, 1989. [PubMed] [Google Scholar]
  • 10. Ertekin C, Keskin A, Kiylioglu N, et al. The effect of head and neck positions on oropharyngeal swallowing: a clinical and electrophysiologic study. Arch Phys Med Rehabil 82: 1255-1260, 2001. [DOI] [PubMed] [Google Scholar]
  • 11. Lazarus CL, Logemann JA, Rademaker AW, et al. Effects of bolus volume, viscosity, and repeated swallows in nonstroke subjects and stroke patients. Arch Phys Med Rehabil 74: 1066-1070, 1993. [DOI] [PubMed] [Google Scholar]
  • 12. Bisch EM, Logemann JA, Rademaker AW, Kahrilas PJ, Lazarus CL. Pharyngeal effects of bolus volume, viscosity, and temperature in patients with dysphagia resulting from neurologic impairment and in normal subjects. J Speech Hear Res 37: 1041-1059, 1994. [DOI] [PubMed] [Google Scholar]
  • 13. Guillén-Solà A, Marco E, Martínez-Orfila J, et al. Usefulness of the volume-viscosity swallow test for screening dysphagia in subacute stroke patients in rehabilitation income. NeuroRehabilitation 33: 631-638, 2013. [DOI] [PubMed] [Google Scholar]
  • 14. Ohmae Y, Logemann JA, Kaiser P, Hanson DG, Kahrilas PJ. Effects of two breath-holding maneuvers on oropharyngeal swallow. Ann Otol Rhinol Laryngol 105: 123-131, 1996. [DOI] [PubMed] [Google Scholar]
  • 15. Bülow M, Olsson R, Ekberg O. Videomanometric analysis of supraglottic swallow, effortful swallow, and chin tuck in patients with pharyngeal dysfunction. Dysphagia 16: 190-195, 2001. [DOI] [PubMed] [Google Scholar]
  • 16. Mendelsohn MS, Martin RE. Airway protection during breath-holding. Ann Otol Rhinol Laryngol 102: 941-944, 1993. [DOI] [PubMed] [Google Scholar]
  • 17. McCullough GH, Kamarunas E, Mann GC, Schmidley JW, Robbins JA, Crary MA. Effects of Mendelsohn maneuver on measures of swallowing duration post stroke. Dysphagia 28: 511-519, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Mepani R, Antonik S, Massey B, et al. Augmentation of deglutitive thyrohyoid muscle shortening by the shaker exercise. Dysphagia 24: 26-31, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Easterling C, Grande B, Kern M, Sears K, Shaker R. Attaining and maintaining isometric and isokinetic goals of the Shaker exercise. Dysphagia 20: 133-138, 2005. [DOI] [PubMed] [Google Scholar]
  • 20. Yamamoto T, Kobayashi Y, Murata M. Risk of pneumonia onset and discontinuation of oral intake following videofluorography in patients with levy body disease. Parkinsonism Relat Disord 16: 503-506, 2010. [DOI] [PubMed] [Google Scholar]
  • 21. Vose A, Nonnenmacher J, Singer ML, Gonzalez-Femandez M. Dysphagia management in acute and sub-acute stroke. Curr Phys Med Rep 2: 197-206, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Mann G, Hankey GJ, Cameron D. Swallowing function after stroke. Stroke 30: 744-748, 1999. [DOI] [PubMed] [Google Scholar]
  • 23. Heckert KD, Konnaroff E, Adler U, Barrett AM. Post acute reevaluation may prevent dysphagia- associated morbidity. Stroke 40: 1381-1385, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Palmer JB, Kuhlemeier KV, Tippett DC, Lynch C. A protocol for the videofluorographic study. Dysphagia 8: 209-214, 1993. [DOI] [PubMed] [Google Scholar]
  • 25. Food trialists collaboration Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomized controlled trial. Lancet 365: 764-772, 2005. [DOI] [PubMed] [Google Scholar]
  • 26. Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol 8: 401-410, 2012. [DOI] [PubMed] [Google Scholar]
  • 27. Gosney M, Martin MV, Wright AE. The role of selective decontamination of the digestive tract in acute stroke. Age Ageing 33: 42-47, 2006. [DOI] [PubMed] [Google Scholar]
  • 28. Rozas NS, Sadowsky JM, Jones DJ, Jeter CB. Incorporating oral health into interprofessional care teams for patients with Parkinson's disease. Parkinsonism Relat Disord 43: 9-14, 2017. [DOI] [PubMed] [Google Scholar]
  • 29. Kalra L, Irshad S, Hodsoll J, et al. Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised open-label, masked endpoint, controlled clinical trial. Lancet 386: 1833-1844, 2015. [DOI] [PubMed] [Google Scholar]
  • 30. Westendorp WF, Vermeij J-D, Zock E, et al. The preventive antibiotics in stroke study (PASS): a pragmatic randomized open-label masked endpoint clinical trial. Lancet 385: 1519-1526, 2015. [DOI] [PubMed] [Google Scholar]
  • 31. Smithard DG, O'Neil PA, England RE, et al. The natural history of dysphagia following stroke. Dysphagia 12: 188-193, 1997. [DOI] [PubMed] [Google Scholar]
  • 32. Manor Y, Giladi N, Cohen A, Fliss DM, Cohen JT. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease. Mov Disord 22: 1917-1921, 2007. [DOI] [PubMed] [Google Scholar]
  • 33. Simons JA, Fietzek UM, Waldmann A, Warnecke T, Schuster T, Ceballos-Baumann AO. Development and validation of a new screening questionnaire for dysphagia in early stages of Parkinson's disease. Parkinsonism Relat Disord 20: 992-998, 2014. [DOI] [PubMed] [Google Scholar]
  • 34. Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia 11: 93-98, 1996. [DOI] [PubMed] [Google Scholar]
  • 35. Han TR, Paik NJ, Park JW, Kwon BS. The prediction of persistent dysphagia beyond six months after stroke. Dysphagia 23: 59-64, 2008. [DOI] [PubMed] [Google Scholar]
  • 36. Tomita S, Oeda T, Umemura A, et al. Video-fluoroscopic swallowing study scale for predicting aspiration pneumonia in Parkinson's disease. PLoS One 13: e0197608, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 5: 235-245, 2006. [DOI] [PubMed] [Google Scholar]
  • 38. Suntrup S, Teismann I, Bejer J, et al. Evidence for adaptive cortical changes in swallowing in Parkinson's disease. Brain 136: 726-738, 2013. [DOI] [PubMed] [Google Scholar]
  • 39. Leopold NA, Daniels SK. Supranuclear control of swallowing. Dysphagia 25: 250-257, 2010. [DOI] [PubMed] [Google Scholar]
  • 40. Braak H, Müller CM, Rüb U, et al. Pathology associated with sporadic Parkinson's disease-where does it end? J Neural Transm Suppl: 99-103, 2006. [DOI] [PubMed] [Google Scholar]
  • 41. Ertekin C, Tarlaci S, Aydogdu I, et al. Electrophysiological evaluation of pharyngeal phase of swallowing in patients with Parkinson's disease. Mov Disord 17: 942-949, 2002. [DOI] [PubMed] [Google Scholar]
  • 42. Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson disease. J Neuropathol Exp Neurol 71: 520-530, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Mu L, Sobotka S, Chen J, et al. Parkinson disease affects peripheral sensory nerves in the pharynx. J Neuropathol Exp Neurol 72: 614-623, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Kalf J, de Swart B, Bloem B, Munneke M. Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord 18: 311-315, 2012. [DOI] [PubMed] [Google Scholar]
  • 45. Miller N, Allcock L, Hildreth AJ, Jones D, Noble E, Burn DJ. Swallowing problems in Parkinson disease: frequency and clinical correlates. J Neurol Neurosurg Psychiatr 80: 1047-1049, 2009. [DOI] [PubMed] [Google Scholar]
  • 46. Sapir S, Ramig L, Fox C. Speech and swallowing in Parkinson disease. Curr Opin Otolaryngol Head Neck Surg 16: 205-210, 2008. [DOI] [PubMed] [Google Scholar]
  • 47. Edwards L, Quiglex EM, Hofmann R, Pfeiffer RF. Gastrointestinal symptoms in Parkinson's disease: 18-month-follow-up study. Mov Disord 8: 83-86, 1993. [DOI] [PubMed] [Google Scholar]
  • 48. Barone P, Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 24: 1641-1649, 2009. [DOI] [PubMed] [Google Scholar]
  • 49. Muller J, Wenning GK, Verny J, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 58: 259-264, 2001. [DOI] [PubMed] [Google Scholar]
  • 50. Umemoto G, Tsuboi Y, Kitashima A, Furuya H, Kikuta T. Impaired food transportation in Parkinson's disease related to lingual bradykinesia. Dysphagia 26: 250-255, 2011. [DOI] [PubMed] [Google Scholar]
  • 51. Coelho M, Marti MJ, Tolosa E, et al. Late-stage Parkinson's disease: the Barcelona and Lisbon cohort. J Neurol 257: 1524-1532, 2010. [DOI] [PubMed] [Google Scholar]
  • 52. Lam K, Lam FK, Lau KK, et al. Simple clinical tests may predict severe oropharyngeal dysphagia in Parkinson's disease. Mov Disord 22: 640-644, 2007. [DOI] [PubMed] [Google Scholar]
  • 53. Norbrega AC, Rodriguez B, Melo A. Silent aspiration in Parkinson's disease patients with diurnal sialorrhea. Clin Neurol Nuerosurg 110: 117-119, 2008. [DOI] [PubMed] [Google Scholar]
  • 54. Warnecke T, Hamacher C, Oelenberg S, Dziewas R. Off and on state assessment of swallowing function in Parkinson's disease. Parkinsonism Relat Disord 20: 1033-1034, 2014. [DOI] [PubMed] [Google Scholar]
  • 55. Cereda E, Cilia R, Klersy C, et al. Swallowing disturbances in Parkinson's disease: a multivariate analysis of contributing factors. Parkinsonism Relat Disord 20: 1382-1387, 2014. [DOI] [PubMed] [Google Scholar]
  • 56. Suttrup I, Warnecke T. Dysphagia in Parkinson's disease. Dysphagia 31: 24-32, 2016. [DOI] [PubMed] [Google Scholar]
  • 57. Ali GN, Wallace KL, Schwartz R, Decarle DJ, Zagami AS, Cook IJ. Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology 110: 383-392, 1996. [DOI] [PubMed] [Google Scholar]
  • 58. Yoritaka A, Shimo Y, Takanashi M, et al. Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks. Parkinsonism Relat Disord 19: 725-731, 2013. [DOI] [PubMed] [Google Scholar]
  • 59. Sato K, Hatano T, Yamashiro K, et al. Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations. Mov Disord 21: 1384-1395, 2006. [DOI] [PubMed] [Google Scholar]
  • 60. Beyer MK, Herlofson K, Arsland D, Larsen JP. Causes of death in a community-based study of Parkinson's disease. Acta Neurol Scand 103: 7-11, 2001. [DOI] [PubMed] [Google Scholar]
  • 61. Langmore SE, Terpenning MS, Schork A, et al. Predictors of aspiration pneumonia: how important is dysphagia? Dysphagia 13: 69-81, 1998. [DOI] [PubMed] [Google Scholar]
  • 62. van der Maarel-Wierink CD, Vanobbergen JN, Bronkhorst EM, Schols JM, de Baat C. Risk factors for aspiration pneumonia in frail older people: a systematic literature review. J Am Med Dir Assoc 12: 344-354, 2011. [DOI] [PubMed] [Google Scholar]
  • 63. Ebihara S, Saito H, Kanda A, et al. Impaired efficacy of cough in patients with Parkinson disease. Chest 124: 1009-1015, 2003. [DOI] [PubMed] [Google Scholar]
  • 64. Fujioka S, Fukae J, Ogura H, et al. Hospital-based study on emergency admission of patients with Parkinson's disease. eNeurologicalSci 4: 19-21, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. Tison F, Wiart L, Guatterie M, et al. Effects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease. Mov Disord 11: 729-732, 1996. [DOI] [PubMed] [Google Scholar]
  • 66. Bushmann M, Dobmeyer SM, Leeker L, Perlmutter JS. Swallowing abnormalities and their response to treatment in Parkinson's disease. Neurology 39: 1309-1314, 1989. [DOI] [PubMed] [Google Scholar]
  • 67. Calne DB, Shaw DG, Spiers AS, Stern GM. Swallowing in Parkinsonism. Br J Radiol 43: 456-457, 1970. [DOI] [PubMed] [Google Scholar]
  • 68. Hunter PC, Crameri J, Austin S, Woodward MC, Hughes J. Response of parkinsonian swallowing dysfunction to dopaminergic stimulation. J Neurol Neurosurg Psychiatry 63: 579-583, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Lim A, Leow L, Huckabee ML, Frampton C, Anderson T. A pilot study of respiration and swallowing integration in Parkinson's disease: “on” and “off” levodopa. Dysphagia 23: 76-81, 2008. [DOI] [PubMed] [Google Scholar]
  • 70. Mu L, Sobotka S, Chen J, et al. Altered pharyngeal muscles in Parkinson disease. Neuropathol Exp Neurol 71: 520-530, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 19: 783-788, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Lengerer S, Kipping J, Rommel N, et al. Deep brain stimulation does not impair deglutition in Parkinson's disease. Parkinsonism Relat Disord 18: 847-853, 2012. [DOI] [PubMed] [Google Scholar]
  • 73. Sunstedt S, Olofsson K, van Doorn J, et al. Swallowing function in Parkinson's patients following zona incerta deep brain stimulation. Acta Neurol Scand 126: 350-356, 2012. [DOI] [PubMed] [Google Scholar]
  • 74. Kulneff L, Sundstedt S, Olofsson K, et al. Deep brain stimulation-effects on swallowing function in Parkinson's disease. Acta Neurol Scand 1: 1-8, 2012. [DOI] [PubMed] [Google Scholar]
  • 75. Silbergleit AK, Lewitt P, Junn F, et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease. Mov Disord 27: 1763-1768, 2012. [DOI] [PubMed] [Google Scholar]
  • 76. Kitashima A, Umemoto G, Tsuboi Y, Higuchi MA, Baba Y, Kikuta T. Effects of subthalamic nucleus deep brain stimulation on the swallowing function of patients with Parkinson's disease. Parkinsonism Relat Disord 19: 480-482, 2013. [DOI] [PubMed] [Google Scholar]
  • 77. Ciucci MR, Brakmeier-Kraemer JM, Shermann SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov Disord 23: 676-683, 2008. [DOI] [PubMed] [Google Scholar]
  • 78. Xie T, Vigil J, MacCracken E, et al. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology 84: 415-420, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Fuh JL, Lee RC, Wang SJ, et al. Swallowing difficulty in Parkinson's disease. Clin Neurol Neurosurg 99: 106-112, 1997. [DOI] [PubMed] [Google Scholar]
  • 80. Nobrega AC, Rodrigues B, Torres AC, Scarper RD, Neves CA, Melo A. Is drooling secondary to a swallowing disorder in patients with Parkinson's disease. Parkinsonism Relat Disord 14: 243-245, 2008. [DOI] [PubMed] [Google Scholar]
  • 81. Angolo N, Sampaio M, Pinho P, Melo A, Nobrega AC. Swallowing disorders in Parkinson's disease: impact of lingual pumping. Int J Lang Commun Disord 50: 659-664, 2015. [DOI] [PubMed] [Google Scholar]
  • 82. Wakasugi Y, Yamamoto T, Oda C, Murata M, Tohara H, Minakuchi S. Effect of an impaired oral stage swallowing in patients with Parkinson's disease. J Oral Rehabil 44: 756-762, 2017. [DOI] [PubMed] [Google Scholar]
  • 83. Silverman EP, Sapienza CM, Saleem A, et al. Tutorial on maximum inspiratory and expiratory mouth pressures in individuals with idiopathic Parkinson disease (IPD) and the preliminary results of an expiratory muscle strength training program. NeuroRehabilitation 21: 71-79, 2006. [PubMed] [Google Scholar]
  • 84. Pitts T, Bolser D, Rosenbek J, Troche M, Okun MS, Sapienza C. Impact of expiratory muscle strength training on voluntary cough and swallow function in Parkinson disease. Chest 135: 1301-1308, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Troche MS, Okun MS, Rosenbek JC, et al. Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology 75: 1912-1919, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. van Hooren MR, Baijens LW, Voskuilen S, Oosterloo M, Kremer B. Treatment effects for dysphagia in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 20: 800-807, 2014. [DOI] [PubMed] [Google Scholar]
  • 87. El Sharkawi A, Ramig L, Logemann JA, et al. Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT): a pilot study. J Neurol Neurosurg Psychiatry 72: 31-36, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Müller J, Wenning GK, Verny M, et al. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders. Arch Neurol 58: 259-264, 2001. [DOI] [PubMed] [Google Scholar]
  • 89. Nath U, Thomson R, Wood R, et al. Population based mortality and quality of death certification in progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psychiatry 76: 498-502, 2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Litvan I, Sastry N, Sonies BC. Characterizing swallowing abnormalities in progressive supranuclear palsy. Neurology 48: 1654-1662, 1997. [DOI] [PubMed] [Google Scholar]
  • 91. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60: 615-620, 1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Varanese S, Di Ruscio P, Ben M' Barek L, Thomas A, Onofrj M. Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy. J Neurol 261: 441-442, 2014. [DOI] [PubMed] [Google Scholar]
  • 93. Warnecke T, Oelenberg S, Teismann I, et al. Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. Mov Disord 25: 1239-1245, 2010. [DOI] [PubMed] [Google Scholar]
  • 94. Tomita S, Oeda T, Umemura A, et al. Impact of aspiration pneumonia on the clinical course of progressive supranuclear palsy: a retrospective cohort study. PLoS One 10: e0135823, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Maher ER, Lees AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 36: 1005-1008, 1986. [DOI] [PubMed] [Google Scholar]
  • 96. Golbe LI, Davis PH, Schoenberg BS, Duvoisin RC. Prevalence and natural history of progressive supranuclear palsy. Neurology 38: 1031-1034, 1988. [DOI] [PubMed] [Google Scholar]
  • 97. Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G. Comparison of natural histories of PSP and multiple system atrophy. Neurol Sci 22: 247-251, 2001. [DOI] [PubMed] [Google Scholar]
  • 98. Wenning GK, Geser F, Krismer F, et al. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol 12: 264-274, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Coon EA, Sletten DM, Suarez MD, et al. Clinical features and autonomic testing predict survival in multiple system atrophy. Brain 138: 3623-3631, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Watanabe H, Saito Y, Terao S, et al. Progression and prognosis in multiple system atrophy - an analysis of 230 Japanese patients. Brain 125: 1070-1083, 2002. [DOI] [PubMed] [Google Scholar]
  • 101. Umemoto G, Furuya H, Tsuboi Y, et al. Dysphagia in multiple system atrophy of cerebellar and parkinsonian types. J Neurol Neurosci 8: 165, 2017. [Google Scholar]

Articles from Internal Medicine are provided here courtesy of Japanese Society of Internal Medicine

RESOURCES